Taxotere-Enoxaparin-(ENOXA)-Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
Taxotere-Enoxaparin-(ENOXA)-Study: 1st-Line Docetaxel-Platin Chemotherapy as single therapy or in combination with Enoxaparin in patients aged older than 18 years with locally advanced or metastatic non-small cell lung cancer (stadium IIIb/IV), a phase III study. Study hypothesis: Increase of progressive free survival from 5 to 7.5 months.
Epistemonikos ID: 974a83b6d24e2bbb5a649e77c029ad137ebf9096
First added on: May 05, 2024